The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms.

Panattoni LE., J Health Econ. 30(1):126-45. doi: 10.1016/j.jhealeco.2010.09.004. Epub 2010 Oct 8., 2011 Jan 01

Abstract

This purpose of this paper is to investigate the impact of Paragraph IV patent infringement decisions on brand drug pharmaceutical firms. Paragraph IV decisions determine whether a generic firm can enter before the period of exclusivity ends.

I construct a novel dataset of all Paragraph IV decisions and find that they disproportionately involve the highest revenue drugs, significant periods of patent protection, and a non-trivial portion of all brand drugs facing generic entry.

I also estimate the impact of Paragraph IV decisions on brand firm profitability and find they have large value consequences.

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

Related Publications

HOMBRE: A randomized controlled trial to compare two approaches to weight loss for overweight and obese Latino men (men with choices to improve well-being and decrease chronic disease risk).

Rosas LG, Lv N, Azar KMJ, Xiao L, Hooker SP, Lewis MA, Zavella P, Venditti EM, Ma J.
Contemp Clin Trials. pii: S1551-7144(17)30629-8. doi: 10.1016/j.cct.2018.02.019. [Epub ahead of print]
2018 Mar 02

Personalized hypertension management using patient-generated health data integrated with electronic health records (EMPOWER-H): six-month pre-post study.

Lv N, Xiao L, Simmons ML, Rosas LG, Chan A, Entwistle M.
J Med Internet Res. 19(9):e311. doi: 10.2196/jmir.7831.
2017 Sep 19

A framework for examining the function of digital health technologies for weight management.

Azar KMJ, Bennett GG, Nolting LA, Rosas LG, Burke LE, Ma J.
Transl Behav Med. doi: 10.1093/tbm/ibx050. [Epub ahead of print]
2018 Jan 27

Implementation of patient-reported outcomes measurement information system data collection in a private orthopedic surgery practice.

Haskell A, Kim T.
Foot Ankle Int. 1071100717753967. doi: 10.1177/1071100717753967. [Epub ahead of print]
2018 Jan 01

Framework for research on implementation of process redesigns.

Ashok M, Hung D, Rojas-Smith L, Halpern MT, Harrison M.
Qual Manag Health Care. 27(1):17-23. doi: 10.1097/QMH.0000000000000158.
2018 Jan 01

We've expanded your view

The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms.

Abstract

Pubmed Abstract

Associated Topics

Related Publications

HOMBRE: A randomized controlled trial to compare two approaches to weight loss for overweight and obese Latino men (men with choices to improve well-being and decrease chronic disease risk).

Personalized hypertension management using patient-generated health data integrated with electronic health records (EMPOWER-H): six-month pre-post study.

A framework for examining the function of digital health technologies for weight management.

Implementation of patient-reported outcomes measurement information system data collection in a private orthopedic surgery practice.

Framework for research on implementation of process redesigns.

About Sutter

Find Care

Featured Services

Patient Resources

Our Team